Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

Show other versions (1)

INTRODUCTION: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39. METHODS: Oligonucleotide microarray platforms were used for gene expression and pathway analysis. Confirmation studies were performed using quantitativ...

Full description

Bibliographic Details
Main Authors: Hakan Savlı, Sara Galimberti, Deniz Sünnetçi, Martina Canesastraro, Giuseppe Palumbo, Balint Nagy, Francesco Di Raimondo, Mario Petrini
Format: Article
Language:English
Published: Galenos Publishing House 2015-07-01
Series:Turkish Journal of Hematology
Subjects:
bortezomib
arsenic trioxide
nf-κ
b
mds
gene expression
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-78309

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-78309

Similar Items